GSK logo

GSK (GSK) Working Capital

GSK Annual Working Capital

-$3.09 B
-$617.92 M-25.02%

31 December 2023

GSK Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Quarterly Working Capital

-$5.57 B
-$1.04 B-22.94%

30 September 2024

GSK Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.0%-80.3%
3 y3 years-19.2%-190.0%
5 y5 years+56.3%-190.0%

GSK Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.0%+54.2%-128.1%+17.4%
5 y5-year-25.0%+54.2%-128.1%+17.4%
alltimeall time-129.1%+78.6%-128.1%+65.4%

GSK Working Capital History

DateAnnualQuarterly
Sept 2024
-
-$5.57 B(+22.9%)
June 2024
-
-$4.53 B(+35.8%)
Mar 2024
-
-$3.33 B(+8.0%)
Dec 2023
-$3.09 B(+25.0%)
-$3.09 B(+120.1%)
Sept 2023
-
-$1.40 B(-59.7%)
June 2023
-
-$3.48 B(+187.7%)
Mar 2023
-
-$1.21 B(-51.0%)
Dec 2022
-$2.47 B(-63.4%)
-$2.47 B(+214.2%)
Sept 2022
-
-$786.16 M(-104.0%)
June 2022
-
$19.83 B(+220.6%)
Mar 2022
-
$6.19 B(-191.8%)
Dec 2021
-$6.74 B(+160.3%)
-$6.74 B(+20.6%)
Sept 2021
-
-$5.59 B(+5.7%)
June 2021
-
-$5.29 B(+119.7%)
Mar 2021
-
-$2.41 B(-7.1%)
Dec 2020
-$2.59 B(-56.7%)
-$2.59 B(-12.4%)
Sept 2020
-
-$2.96 B(+153.9%)
June 2020
-
-$1.16 B(-71.6%)
Mar 2020
-
-$4.10 B(-31.5%)
Dec 2019
-$5.98 B(-15.3%)
-$5.98 B(+7.5%)
Sept 2019
-
-$5.56 B(-41.9%)
June 2019
-
-$9.57 B(+5.8%)
Mar 2019
-
-$9.05 B(+28.1%)
Dec 2018
-$7.06 B(-51.0%)
-$7.06 B(+454.6%)
Sept 2018
-
-$1.27 B(-15.6%)
June 2018
-
-$1.51 B(-89.8%)
Mar 2018
-
-$14.72 B(+2.2%)
Dec 2017
-$14.41 B(+412.2%)
-$14.41 B(+9.7%)
Sept 2017
-
-$13.14 B(-18.3%)
June 2017
-
-$16.08 B(+554.3%)
Mar 2017
-
-$2.46 B(-12.6%)
Dec 2016
-$2.81 B(-159.9%)
-$2.81 B(+313.4%)
Sept 2016
-
-$680.56 M(-58.8%)
June 2016
-
-$1.65 B(-160.2%)
Mar 2016
-
$2.74 B(-41.6%)
Dec 2015
$4.70 B(+118.2%)
$4.70 B(-26.8%)
Sept 2015
-
$6.41 B(-5.6%)
June 2015
-
$6.79 B(-9.7%)
Mar 2015
-
$7.52 B(+249.3%)
Dec 2014
$2.15 B(-15.8%)
$2.15 B(-424.1%)
Sept 2014
-
-$664.24 M(-130.0%)
June 2014
-
$2.22 B(-15.6%)
Mar 2014
-
$2.63 B(+2.8%)
Dec 2013
$2.56 B(-1385.9%)
$2.56 B(+147.0%)
Sept 2013
-
$1.03 B(-29.3%)
June 2013
-
$1.46 B(-54.4%)
Mar 2013
-
$3.20 B(-1712.4%)
Dec 2012
-$198.77 M(-111.1%)
-$198.77 M(-74.0%)
Sept 2012
-
-$764.39 M(-126.5%)
June 2012
-
$2.89 B(+3.8%)
Mar 2012
-
$2.78 B(+56.2%)
Dec 2011
$1.78 B(-64.4%)
$1.78 B(-65.2%)
Sept 2011
-
$5.13 B(+18.6%)
June 2011
-
$4.32 B(-27.1%)
Mar 2011
-
$5.93 B(+18.5%)
Dec 2010
$5.00 B
$5.00 B(-42.9%)
Sept 2010
-
$8.77 B(+15.5%)
June 2010
-
$7.59 B(-19.4%)
DateAnnualQuarterly
Mar 2010
-
$9.42 B(+6.8%)
Dec 2009
$8.82 B(-17.0%)
$8.82 B(-11.4%)
Sept 2009
-
$9.95 B(-2.7%)
June 2009
-
$10.23 B(-1.2%)
Mar 2009
-
$10.36 B(-2.5%)
Dec 2008
$10.62 B(+62.8%)
$10.62 B(-3.2%)
Sept 2008
-
$10.97 B(-14.2%)
June 2008
-
$12.78 B(+98.0%)
Mar 2008
-
$6.46 B(-1.0%)
Dec 2007
$6.52 B(-10.6%)
$6.52 B(+35.6%)
Sept 2007
-
$4.81 B(-36.4%)
June 2007
-
$7.56 B(+12.6%)
Mar 2007
-
$6.72 B(-7.9%)
Dec 2006
$7.30 B(+15.8%)
$7.30 B(-15.3%)
Sept 2006
-
$8.61 B(+5.8%)
June 2006
-
$8.14 B(+1.9%)
Mar 2006
-
$7.99 B(+26.7%)
Dec 2005
$6.30 B(+48.3%)
$6.30 B(-20.0%)
Sept 2005
-
$7.88 B(+10.6%)
June 2005
-
$7.12 B(+41.5%)
Mar 2005
-
$5.03 B(+18.4%)
Dec 2004
$4.25 B(-40.9%)
$4.25 B(-30.6%)
Sept 2004
-
$6.13 B(+13.2%)
June 2004
-
$5.41 B(+181.8%)
Mar 2004
-
$1.92 B(-73.3%)
Dec 2003
$7.19 B(+129.9%)
$7.19 B(-6.2%)
Sept 2003
-
$7.67 B(+13.3%)
June 2003
-
$6.77 B(+72.8%)
Mar 2003
-
$3.92 B(+25.2%)
Dec 2002
$3.13 B(+280.1%)
$3.13 B(+55.5%)
Sept 2002
-
$2.01 B(+41.4%)
June 2002
-
$1.42 B(-26.5%)
Mar 2002
-
$1.94 B(+135.3%)
Dec 2001
$823.34 M(-74.7%)
$823.34 M(-67.5%)
Sept 2001
-
$2.53 B(-11.0%)
June 2001
-
$2.84 B(+29.7%)
Mar 2001
-
$2.19 B(-32.7%)
Dec 2000
$3.26 B(+146.6%)
$3.26 B(+28.1%)
Sept 2000
-
$2.54 B(+36.5%)
June 2000
-
$1.86 B(+35.3%)
Mar 2000
-
$1.38 B(+4.3%)
Dec 1999
$1.32 B(-41.5%)
$1.32 B(-44.8%)
June 1999
-
$2.39 B(+6.0%)
Dec 1998
$2.26 B(+48.7%)
$2.26 B(+11.6%)
June 1998
-
$2.02 B(+33.3%)
Dec 1997
$1.52 B(+317.1%)
$1.52 B(+317.1%)
Dec 1996
$363.69 M(-119.8%)
$363.69 M(-59.8%)
Dec 1995
-$1.84 B(-303.2%)
-
June 1995
-
$905.52 M(-76.7%)
June 1995
$905.52 M(-76.7%)
-
June 1994
$3.88 B(+14.9%)
$3.88 B(+14.9%)
June 1993
$3.38 B(+2.1%)
$3.38 B(+2.1%)
June 1992
$3.31 B(+26.8%)
$3.31 B(+26.8%)
June 1991
$2.61 B(+2.6%)
$2.61 B(+2.6%)
June 1990
$2.54 B(+15.6%)
$2.54 B(+15.6%)
June 1989
$2.20 B(+15.3%)
$2.20 B(+15.3%)
June 1988
$1.91 B(+25.2%)
$1.91 B(+25.2%)
June 1987
$1.52 B(+50.3%)
$1.52 B(+50.3%)
June 1986
$1.01 B
$1.01 B

FAQ

  • What is GSK annual working capital?
  • What is the all time high annual working capital for GSK?
  • What is GSK annual working capital year-on-year change?
  • What is GSK quarterly working capital?
  • What is the all time high quarterly working capital for GSK?
  • What is GSK quarterly working capital year-on-year change?

What is GSK annual working capital?

The current annual working capital of GSK is -$3.09 B

What is the all time high annual working capital for GSK?

GSK all-time high annual working capital is $10.62 B

What is GSK annual working capital year-on-year change?

Over the past year, GSK annual working capital has changed by -$617.92 M (-25.02%)

What is GSK quarterly working capital?

The current quarterly working capital of GSK is -$5.57 B

What is the all time high quarterly working capital for GSK?

GSK all-time high quarterly working capital is $19.83 B

What is GSK quarterly working capital year-on-year change?

Over the past year, GSK quarterly working capital has changed by -$2.48 B (-80.32%)